Yayın:
Chemosensitizing effect of apigenin on T-ALL cell therapy

Sadeleştirilmiş öğe sayfası
dc.contributor.authorNigar Huseynova
dc.contributor.authorZüleyha Baran
dc.contributor.authorRovshan Khalilov
dc.contributor.authorAfat Mammadova
dc.contributor.authorYusuf Baran
dc.contributor.orcid0009-0001-8287-3555
dc.contributor.orcid0000-0002-8684-1390
dc.contributor.orcid0000-0002-1056-4673
dc.date.accessioned2026-05-20T10:04:30Z
dc.date.issued2025-10-31
dc.identifier.doi10.3389/fphar.2025.1631505
dc.identifier.endpage1631505
dc.identifier.issn1663-9812
dc.identifier.openalexW4415723146
dc.identifier.startpage1631505
dc.identifier.urihttps://hdl.handle.net/11421/39310
dc.identifier.urihttps://doi.org/10.3389/fphar.2025.1631505
dc.identifier.volume16
dc.language.isoen
dc.relation.ispartofFrontiers in Pharmacology
dc.rightsopenAccess
dc.subjectApigenin
dc.subjectApoptosis
dc.subjectCytotoxicity
dc.subjectCell cycle
dc.subjectMTT assay
dc.subjectCell cycle checkpoint
dc.subjectCombination therapy
dc.subjectAnnexin
dc.subjectChemosensitizer
dc.titleChemosensitizing effect of apigenin on T-ALL cell therapy
dspace.entity.typePublication

Dosyalar

Koleksiyonlar

Publications